Duncan Gallagher - 01 Mar 2025 Form 4 Insider Report for Health Catalyst, Inc. (HCAT)

Role: Director
Signature: /s/Benjamin Landry, as Attorney-in-Fact
Issuer symbol: HCAT
Transactions as of: 01 Mar 2025
Transactions value $: $0
Form type: 4
Filing time: 04 Mar 2025, 17:20:28 UTC
Previous filing: 02 Jan 2025
Next filing: 03 Jun 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HCAT	Common Stock	Award	$0	+3,033	+4.34%	$0	72,971	01 Mar 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents an award of the Issuer's restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan and in accordance with the terms of Issuer's Non-Employee Director Compensation Policy, 100% of such RSUs vested on March 1, 2025.

Content

Represents an award of the Issuer's restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan and in accordance with the terms of Issuer's Non-Employee Director Compensation Policy, 100% of such RSUs vested on March 1, 2025.